MENU
ARX
AS OF
Feb 4 closing price
Price
$12.06
Change
+$0.30 (+2.55%)
Capitalization
2.68B
20 days until earnings call
Intraday BUY SELL Signals
+Compare
ARX
Stock ticker: NYSE
AS OF
Feb 4 closing price
Price
$12.06
Change
+$0.30 (+2.55%)
Capitalization
2.68B

ARX stock forecast, quote, news & analysis

Accelerant Holdings operate as a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners... Show more

ARX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ARX with price predictions
Feb 03, 2026

Momentum Indicator for ARX turns negative, indicating new downward trend

ARX saw its Momentum Indicator move below the 0 level on January 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 3 similar instances where the indicator turned negative. In of the 3 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARX entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ARX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.957) is normal, around the industry mean (6.308). ARX has a moderately high P/E Ratio (68.176) as compared to the industry average of (31.478). ARX's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.475). ARX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.186) is also within normal values, averaging (3.265).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 14.27B. The market cap for tickers in the group ranges from 419.6K to 92.03B. MRSH holds the highest valuation in this group at 92.03B. The lowest valued company is ARGQD at 419.6K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -5%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -28%. KG experienced the highest price growth at 18%, while TIRX experienced the biggest fall at -53%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 856%. For the same stocks of the Industry, the average monthly volume growth was 1,532% and the average quarterly volume growth was 955%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 77
P/E Growth Rating: 83
Price Growth Rating: 72
SMR Rating: 62
Profit Risk Rating: 85
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
ARX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Profile
Fundamentals
Details